Alpha 2.0
Login Register
» Authors » June R Rambousek

June R Rambousek

Explore the profile of June R Rambousek including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 0
Followers 0
Related Specialty
Endocrinology
Top 10 Co-Authors
Jared D Slattery
Edison Tsui
Mackenzie K Honeycutt
James E Blevins
Andrew D Dodson
Peter J Havel
Tami Wolden-Hanson
James L Graham
Tomasz A Wietecha
Kevin D OBrien
Published In
bioRxiv
Front Endocrinol (Lausanne)
Front Drug Deliv
Affiliations
Soon will be listed here.
Recent Articles
1.
Sympathetic innervation of interscapular brown adipose tissue is not a predominant mediator of Oxytocin (OT)-elicited reductions of body weight gain and adiposity in male diet-induced obese rats
Edwards M, Nguyen H, Dodson A, Herbertson A, Honeycutt M, Slattery J, et al.
Front Drug Deliv . 2025 Jan; 4. PMID: 39866535
Recent studies indicate that central administration of oxytocin (OT) reduces body weight (BW) in high fat diet-induced obese (DIO) rodents by reducing energy intake and increasing energy expenditure (EE). Previous...
2.
Effects of systemic oxytocin and beta-3 receptor agonist (CL 316243) treatment on body weight and adiposity in male diet-induced obese rats
Slattery J, Rambousek J, Tsui E, Honeycutt M, Goldberg M, Graham J, et al.
bioRxiv . 2024 Nov; PMID: 39502365
Previous studies have implicated hindbrain oxytocin (OT) receptors in the control of food intake and brown adipose tissue (BAT) thermogenesis. We recently demonstrated that hindbrain [fourth ventricle (4V)] administration of...
3.
Sympathetic innervation of interscapular brown adipose tissue is not a predominant mediator of OT-elicited reductions of body weight gain and adiposity in male diet-induced obese rats
Edwards M, Nguyen H, Dodson A, Herbertson A, Honeycutt M, Slattery J, et al.
bioRxiv . 2024 Sep; PMID: 39345420
Recent studies indicate that central administration of oxytocin (OT) reduces body weight (BW) in high fat diet-induced obese (DIO) rodents by reducing energy intake and increasing energy expenditure (EE). Previous...
4.
The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent manner
Blevins J, Honeycutt M, Slattery J, Goldberg M, Rambousek J, Tsui E, et al.
Front Endocrinol (Lausanne) . 2024 Aug; 15:1432928. PMID: 39104812
We recently reported that a novel chimeric peptide (GEP44) targeting both the glucagon-like peptide-1 receptor (GLP-1R) and neuropeptide Y1- and Y2 receptor (Y1R and Y2R) reduced energy intake and body...
5.
The Novel Chimeric Multi-Agonist Peptide (GEP44) Reduces Energy Intake and Body Weight in Male and Female Diet-Induced Obese Mice in a Glucagon-Like Peptide-1 Receptor-Dependent Manner
Blevins J, Honeycutt M, Slattery J, Goldberg M, Rambousek J, Tsui E, et al.
bioRxiv . 2024 Jun; PMID: 38826286
We recently reported that a novel chimeric peptide (GEP44) targeting both the glucagon-like peptide-1 receptor (GLP-1R) and neuropeptide Y1- and Y2 receptor (Y1R and Y2R) reduced energy intake and body...